Education
About Us
Working with TipRanks
Follow Us
Kits Eyecare (TSE:KITS)
TSX:KITS
KITS Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KITS Stock 12 Month Forecast
Average Price Target
C$18.00
▲(18.58%Upside)
| Highest Price TargetC$18.00 | Average Price TargetC$18.00 | Lowest Price TargetC$18.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
C$16.5
Buy
8.70%
Upside
Reiterated
06/05/25
Kits Eyecare's overall stock score of 77 reflects its strong financial performance and positive earnings outlook, driven by impressive revenue growth and strategic investments. The technical indicators support a short-term bullish trend, although the high P/E ratio suggests caution due to high valuation. Corporate events further bolster confidence in the company's future growth prospects.
Stifel Nicolaus
C$18
Buy
18.58%
Upside
Reiterated
05/08/25
Haywood
C$18
Buy
18.58%
Upside
Reiterated
05/07/25
KITS reported Q1/25 revenue/Adj. EBITDA of $46.6M/$3.5M, in line with its preannouncement and versus our $47.0M/$3.3M estimates, and consensus of $46.9M/$3.1M. Gross margin was 36.7% vs our 36% estimate and organic growth continues to impress at 34% - this is the 3rd consecutive quarter of 30%+ organic revenue growth. EBITDA margin benefitted in the quarter from a robust number of repeat customers – 62% of rev in the quarter came from repeat customers. Management guided Q2/25 revenue between $48-50M, a positive surprise, along with 3-5% Adj. EBITDA margin, marginally below where street consensus is – midpoint of EBITDA margin guidance suggests a 50 bps YoY expansion. We attribute the Q2 EBITDA margin guide coming in light versus street expectations of 5% margin due to near-term planned marketing investments attributed to its Own this Town playbook.
Canaccord Genuity
C$14.5
Buy
-4.48%
Downside
Reiterated
03/26/25
Roth MKM
C$16
Buy
5.40%
Upside
Reiterated
03/20/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
C$16.5
Buy
8.70%
Upside
Reiterated
06/05/25
Kits Eyecare's overall stock score of 77 reflects its strong financial performance and positive earnings outlook, driven by impressive revenue growth and strategic investments. The technical indicators support a short-term bullish trend, although the high P/E ratio suggests caution due to high valuation. Corporate events further bolster confidence in the company's future growth prospects.
Stifel Nicolaus
C$18
Buy
18.58%
Upside
Reiterated
05/08/25
Haywood
C$18
Buy
18.58%
Upside
Reiterated
05/07/25
KITS reported Q1/25 revenue/Adj. EBITDA of $46.6M/$3.5M, in line with its preannouncement and versus our $47.0M/$3.3M estimates, and consensus of $46.9M/$3.1M. Gross margin was 36.7% vs our 36% estimate and organic growth continues to impress at 34% - this is the 3rd consecutive quarter of 30%+ organic revenue growth. EBITDA margin benefitted in the quarter from a robust number of repeat customers – 62% of rev in the quarter came from repeat customers. Management guided Q2/25 revenue between $48-50M, a positive surprise, along with 3-5% Adj. EBITDA margin, marginally below where street consensus is – midpoint of EBITDA margin guidance suggests a 50 bps YoY expansion. We attribute the Q2 EBITDA margin guide coming in light versus street expectations of 5% margin due to near-term planned marketing investments attributed to its Own this Town playbook.
Canaccord Genuity
C$14.5
Buy
-4.48%
Downside
Reiterated
03/26/25
Roth MKM
C$16
Buy
5.40%
Upside
Reiterated
03/20/25
Best Analysts Covering Kits Eyecare
1 Month
xxx
Success Rate
7/10 ratings generated profit
Average Return
+1.83%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.00% of your transactions generating a profit, with an average return of +1.83% per trade.
3 Months
xxx
Success Rate
9/11 ratings generated profit
Average Return
+20.93%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 81.82% of your transactions generating a profit, with an average return of +20.93% per trade.
1 Year
Success Rate
10/10 ratings generated profit
Average Return
+57.77%
reiterated a buy rating 2 months ago
Copying Martin Landry's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +57.77% per trade.
2 Years
xxx
Success Rate
11/11 ratings generated profit
Average Return
+93.24%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +93.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KITS Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Jan 25
Mar 25
May 25
Strong Buy
1
4
7
11
10
Buy
8
5
2
4
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
9
9
15
14
Each month's total comprises the sum of three months' worth of ratings.
KITS Financial Forecast
KITS Stock Forecast FAQ
What is TSE:KITS’s average 12-month price target, according to analysts?
Based on analyst ratings, Kits Eyecare’s 12-month average price target is 18.00.
What is TSE:KITS’s upside potential, based on the analysts’ average price target?
Kits Eyecare has 18.58% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:KITS a Buy, Sell or Hold?
Kits Eyecare has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kits Eyecare’s price target?
The average price target for Kits Eyecare is 18.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$18.00 ,the lowest forecast is C$18.00. The average price target represents 18.58% Increase from the current price of C$15.18.
The highest analyst price target is C$18.00 ,the lowest forecast is C$18.00. The average price target represents 18.58% Increase from the current price of C$15.18.
What do analysts say about Kits Eyecare?
Kits Eyecare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of TSE:KITS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.